Disubstituted bis-THF moieties as new P2 ligands in nonpeptidal HIV-1 protease inhibitors

14Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A series of darunavir analogues featuring a substituted bis-THF ring as P2 ligand have been synthesized and evaluated. High affinity protease inhibitors (PIs) with an interesting activity on wild-type HIV and a panel of multi-PI resistant HIV-1 mutants containing clinically observed, primary mutations were identified using a cell-based assay. A number of PIs have been synthesized that show equivalent and greater activity for HIV-1 mutant strains as compared to wild-type HIV-1. The activity on the purified enzyme was confirmed for a selection of analogues. © 2011 American Chemical Society.

Cite

CITATION STYLE

APA

Hohlfeld, K., Tomassi, C., Wegner, J. K., Kesteleyn, B., & Linclau, B. (2011). Disubstituted bis-THF moieties as new P2 ligands in nonpeptidal HIV-1 protease inhibitors. ACS Medicinal Chemistry Letters, 2(6), 461–465. https://doi.org/10.1021/ml2000356

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free